)
Edge15 May 2026
TOMRA: Closing the Loop
The story of TOMRA: from reverse vending machine pioneer to global technology for deposit systems, recycling, and resource optimization.
Bastide Le Confort Médical
Bastide Le Confort Médical (BLC) investor relations material
Bastide Le Confort Médical Q3 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 TU earnings summary13 May, 2026
Executive summary
Nine-month revenue reached €391.9 million, up 7.0% year-over-year, with organic growth at 7.2%.
Home healthcare services grew 8.5%, while Homecare rose 5.2%, despite a one-off impact from the VPH reform in Q3.
The VPH reform temporarily slowed Homecare growth in Q3, but momentum is expected to recover in Q4.
Financial highlights
Q3 2025-2026 revenue was €131.5 million, up 5.0% year-over-year.
Homecare revenue for nine months was €150.9 million, up 5.2%.
Healthcare institutions revenue rose 11.3% to €70.2 million, driven by strong contract performance.
Respiratory business revenue increased 10.2% organically to €130.9 million.
Nutrition-Perfusion-Diabetes-Stomatherapy revenue reached €110.1 million, up 6.5%.
Outlook and guidance
Revenue target for 2025-2026 set at a minimum of €510 million, with a stable operating margin around 9.0%.
Store activity expected to improve in Q4 as the VPH reform impact subsides.
Continued structural growth anticipated in home healthcare services.
Margin impact of VPH shift from rental to sales
Update on asset divestment and debt reduction
Respiratory growth outlook post-Canada ramp-up
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bastide Le Confort Médical
- Net profit jumped to €30.6M on strong revenue growth and asset sales, with leverage down to 2.77x.BLC
H1 202618 Mar 2026 - Revenue up 8% to €260.4M, with robust growth in home healthcare and respiratory segments.BLCQ2 2026 TU12 Feb 2026
- Q1 organic revenue up 8.3%, driven by home healthcare and respiratory growth.BLCQ1 2026 TU13 Nov 2025
- Strong revenue and margin growth, with improved leverage and positive 2025-2026 outlook.BLCH2 202524 Oct 2025
- Q1 revenue up 9.1% to €133.8M; 2024-2025 targets and debt reduction focus reaffirmed.BLCQ1 24/25 TU13 Jun 2025
- Solid revenue and margin gains offset by higher financial costs, with deleveraging prioritized.BLCH2 23/2413 Jun 2025
- Revenue exceeded targets with strong Q4 growth and robust outlook for 2024-2025.BLCH2 23/24 TU13 Jun 2025
- Revenue up 8.4% to €419.4M; 2024-2025 targets and strong growth in technical segments confirmed.BLCQ3 20256 Jun 2025
- Revenue up 4%, margin at 9.1%, robust cash flow, and €375M refinancing secured.BLCH1 20255 Jun 2025
Next Bastide Le Confort Médical earnings date
Q4 2026 TU3 Sep, 2026
Bastide Le Confort Médical
Next Bastide Le Confort Médical earnings date
Q4 2026 TU3 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage